Febuxostat and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Febuxostat (febuxostat) and Potassium (potassium). Common drug interactions include eye pain among females and cerebral haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Febuxostat and Potassium. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 9,693 Febuxostat users. Check the latest studies of Febuxostat.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

On Jul, 13, 2026

78 people who take Febuxostat and Potassium together, and have interactions are studied.

Febuxostat and Potassium drug interactions.

What are the common drug interactions of Febuxostat and Potassium, by gender? *:

female:

Eye pain
Eyelid pain
Infectious thyroiditis (inflammation of the thyroid gland due to infection)
Oedema peripheral (superficial swelling)
Pain in extremity
Respiratory tract infection
Anaemia (lack of blood)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Arthralgia (joint pain)
Atrial thrombosis (blood clot that develops in an artery)

male:

Cerebral haemorrhage (bleeding within the brain)
Drug ineffective
Hyperthermia (body temperature greatly above normal)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Oedema peripheral (superficial swelling)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)
Sepsis (a severe blood infection that can lead to organ failure and death)
Vitamin a deficiency
Vitamin d deficiency

What are the common drug interactions of Febuxostat and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
Cardiac failure
Diarrhoea
Platelet count decreased
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)

30-39:

Cardiac ventricular thrombosis (blood clot in ventricle)
Anaemia (lack of blood)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Atrial thrombosis (blood clot that develops in an artery)
C-reactive protein increased
Cardiac arrest
Cardiac failure
Disease recurrence
Familial mediterranean fever (genetic disease recurring attacks of abdominal pain, fever, pleurisy, arthritis, and rash)
Low cardiac output syndrome (decreased cardiac output)

40-49:

Face oedema (swelling of face)
Hyperthermia (body temperature greatly above normal)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Oedema peripheral (superficial swelling)
Pulmonary embolism (blockage of the main artery of the lung)
Vitamin a deficiency
Vitamin d deficiency
Febrile neutropenia (fever with reduced white blood cells)
Headache (pain in head)
Myocarditis (inflammation of heart muscle myocardium)

50-59:

Renal tubular necrosis (death of kidney tubules)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Acute respiratory distress syndrome
Brain death
Cerebral infarction (less blood supply to brain resulting tissue damage)
Coma (state of unconsciousness lasting more than six hours)
Device related infection
Encephalitis (inflammation of the brain)
Enterococcal infection
Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)

60+:

Cerebral haemorrhage (bleeding within the brain)
Constipation
Nephropathy (damage to or disease of a kidney)
Peripheral swelling
Pneumonia
Rash
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Asthenia (weakness)
C-reactive protein increased

What are the existing conditions these people have? *

High Blood Pressure: 31 people, 39.74%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 23 people, 29.49%
Insomnia (sleeplessness): 21 people, 26.92%
Fever: 18 people, 23.08%
Dyslipidaemia (abnormal amount of lipids): 14 people, 17.95%
Gout (uric acid crystals building up in the body): 13 people, 16.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 13 people, 16.67%
Nausea (feeling of having an urge to vomit): 11 people, 14.10%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 11 people, 14.10%
Thrombosis (formation of a blood clot inside a blood vessel): 10 people, 12.82%

* Approximation only. Some reports may have incomplete information.

Do you take Febuxostat and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously